Scientists have created a risk score based on thousands of genetic variants to determine the prognosis of individual patients with rheumatoid arthritis.
In a study published in Arthritis & Rheumatology, the risk score that was constructed of 43,784 genetic variants significantly differed between patients with severe and non-severe arthritis progression.
“Our study reveals that genetic profiling in… rheumatic diseases has potential applications in precision medicine, which should be validated and improved in future studies,” the authors wrote.